KUALA LUMPUR, July 21 (Bernama) -- CSOP Asset Management Limited (CSOP) has announced the listing of CSOP China Healthcare Disruption Index ETF (stock ticker: 3174.HK) on the Hong Kong Stock Exchange (the HKEX).
According to a statement, 3174.HK will track the performance of the Solactive China Healthcare Disruption Index (the Index).
With listing price at around HKD 7.8 per unit, trading lot of 100 shares and annual management fee of 0.99 per cent, CSOP China Healthcare Disruption Index ETF will start to trade on July 21. (HKD 100 = RM54.56)
Upon inception, 3174.HK has received around HKD 103 million initial investment.
Managing Director, Head of Business Development and Product Strategy & Solutions, Melody He said: “We are delighted to bring another future-themed ETF to our investors. The launch of 3174.HK enables investors to grasp the investment opportunities by pursuing a healthier life more easily and transparently.”
In 2020, the healthcare sector in the Hong Kong stock market showed strong growth momentum and received significant market interest with 23 newly-listed healthcare companies raising a total of HKD 98 billion.
To replicate the robust performance of the fast-growing healthcare industry in Greater China, the Solactive China Healthcare Disruption Index comprehensively invests in up to 35 most representative Hong Kong-listed companies with business operations in mainland China, Hong Kong, Taiwan and Macau.
Based on historical back-testing data, the Index achieves a return of 36.6 per cent over the prior 12 months.
Primarily adopting a physical representative sampling strategy to replicate the index, 3174.HK enables worldwide investors to grasp the investment opportunities of healthcare industry in an easy and transparent way.
As the pioneer ETF issuer in Hong Kong, CSOP has always been dedicated to providing ETFs/ETPs that not only serve the demands of asset allocation, but also present the prospects of investments, with 3174.HK being one of the important members of CSOP future-defining thematic ETFs.
-- BERNAMA
No comments:
Post a Comment